{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:46:20Z","timestamp":1792176380869,"version":"4.4.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12905-5","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:43Z","timestamp":1792173343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The potential of personalized cancer spheroids in precision therapy"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7515-770X","authenticated-orcid":false,"given":"Debolina","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-1485","authenticated-orcid":false,"given":"Subhadip","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir Kumar","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita Ghosh","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"12905_CR1","doi-asserted-by":"publisher","first-page":"e92707","DOI":"10.7759\/CUREUS.92707","volume":"17","author":"KM Almazrouei","year":"2025","unstructured":"Almazrouei KM, Mishra V, Pandya H, Sambhav K, Bhavsar SN (2025) Tumor Microenvironment and Its Role in Cancer Progression: An Integrative Review. Cureus [Internet]. Springer Sci Bus Media LLC 17:e92707 [cited 2026 Jun 7]. https:\/\/doi.org\/10.7759\/CUREUS.92707","journal-title":"Springer Sci Bus Media LLC"},{"key":"12905_CR2","doi-asserted-by":"publisher","unstructured":"Grzywa TM, Paskal W, W\u0142odarski PK (2017) Intratumor and Intertumor Heterogeneity in Melanoma. Transl Oncol [Internet]. Elsevier; [cited 2026 Jun 7];10:956\u201375. https:\/\/doi.org\/10.1016\/J.TRANON.2017.09.007","DOI":"10.1016\/J.TRANON.2017.09.007"},{"key":"12905_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/J.TCB.2019.03.003","volume-title":"Intratumoral heterogeneity: more than just mutations","author":"K Hinohara","year":"2019","unstructured":"Hinohara K, Polyak K (2019) Intratumoral heterogeneity: more than just mutations, vol 29. Elsevier Ltd, p 569. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1016\/J.TCB.2019.03.003. Trends Cell Biol [Internet]"},{"key":"12905_CR4","doi-asserted-by":"publisher","unstructured":"Shah S, D\u2019Souza GGM (2025) Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis. Cells [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); [cited 2026 Jun 9];14:732. https:\/\/doi.org\/10.3390\/CELLS14100732","DOI":"10.3390\/CELLS14100732"},{"key":"12905_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/S41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q et al (2023) Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis [Internet], vol 14. Springer Nature, p 587. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1038\/S41419-023-06110-6","journal-title":"Cell Death Dis [Internet]"},{"key":"12905_CR6","doi-asserted-by":"publisher","unstructured":"Kumar S, Kundu S, Sharawat SK, Sharma A (2025) Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation. Mammalian Genome 2025 37:1 [Internet]. Springer; [cited 2026 Mar 23];37:3. https:\/\/doi.org\/10.1007\/s00335-025-10172-6","DOI":"10.1007\/s00335-025-10172-6"},{"key":"12905_CR7","doi-asserted-by":"publisher","first-page":"e100320","DOI":"10.7759\/CUREUS.100320","volume":"17","author":"AST Gupta","year":"2025","unstructured":"Gupta AST, Kiyawat S, Darshan P, Sambhav Y, Shamshadali K (2025) Tumor Microenvironment in Cancer Biology: A Comprehensive Review of Stromal, Immune, and Vascular Components Driving Malignancy. Cureus [Internet] Springer Sci Bus Media LLC 17:e100320 [cited 2026 Jun 9]; https:\/\/doi.org\/10.7759\/CUREUS.100320","journal-title":"Cureus [Internet] Springer Sci Bus Media LLC"},{"key":"12905_CR8","doi-asserted-by":"publisher","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell [Internet], vol 41. Cell, pp 374\u2013403. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1016\/J.CCELL.2023.02.016","DOI":"10.1016\/J.CCELL.2023.02.016"},{"key":"12905_CR9","doi-asserted-by":"publisher","unstructured":"Kundu S, Akhtar AR, Kumar A, Sharma A (2026) SUV family histone methyltransferases correlate with nuclear lamina remodeling and clinical outcome in cancer: integrative. Nature Publishing Group. [cited 2026 Apr 22]; https:\/\/doi.org\/10.1038\/s41598-026-44020-7. pan-cancer TCGA analysis and experimental evidence. Scientific Reports 2026 [Internet]","DOI":"10.1038\/s41598-026-44020-7"},{"key":"12905_CR10","doi-asserted-by":"publisher","first-page":"e1291","DOI":"10.1002\/CNR2.1291","volume":"5","author":"FU Vaidya","year":"2020","unstructured":"Vaidya FU, Sufiyan Chhipa A, Mishra V, Gupta VK, Rawat SG, Kumar A et al (2020) Molecular and cellular paradigms of multidrug resistance in cancer. Cancer Rep [Internet] John Wiley Sons Inc 5:e1291 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1002\/CNR2.1291","journal-title":"Cancer Rep [Internet] John Wiley Sons Inc"},{"key":"12905_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/S43556-025-00352-W","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, Hu J, Yang Y, Zhang H, Liu Y, Fang Y et al (2025) Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Molecular Biomedicine [Internet], vol 6. Springer Nature, p 111. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1186\/S43556-025-00352-W","journal-title":"Mol Biomed [Internet]"},{"key":"12905_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/S43018-025-00986-3","volume":"6","author":"K Aliazis","year":"2025","unstructured":"Aliazis K, Christofides A, Shah R, Yeo YY, Jiang S, Charest A et al (2025) The tumor microenvironment\u2019s role in the response to immune checkpoint blockade. Nat Cancer [Internet] Nat Res 6:924 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1038\/S43018-025-00986-3","journal-title":"Nat Cancer [Internet] Nat Res"},{"key":"12905_CR13","doi-asserted-by":"publisher","first-page":"1164535","DOI":"10.3389\/FONC.2023.1164535","volume":"13","author":"M Proietto","year":"2023","unstructured":"Proietto M, Crippa M, Damiani C, Pasquale V, Sacco E, Vanoni M et al (2023) Tumor heterogeneity: preclinical models, emerging technologies, and future applications. Front Oncol [Internet] Front Media S A 13:1164535 [cited 2026 Jun 7]; https:\/\/doi.org\/10.3389\/FONC.2023.1164535","journal-title":"Front Oncol [Internet] Front Media S A"},{"key":"12905_CR14","doi-asserted-by":"publisher","unstructured":"Guerrero-L\u00f3pez P, Mart\u00edn-Pardillos A, Bonet-Aleta J, Mosseri A, Hueso JL, Santamaria J et al (2025) 2D versus 3D tumor-on-chip models to study the impact of tumor organization on metabolic patterns in vitro. Scientific Reports 2025 15:1 [Internet]. Nature Publishing Group; [cited 2026 Jun 9];15:19506. https:\/\/doi.org\/10.1038\/s41598-025-03504-8","DOI":"10.1038\/s41598-025-03504-8"},{"key":"12905_CR15","doi-asserted-by":"publisher","unstructured":"Zhang Y, Payab N, Weigelin B, Sch\u00fcrch CM (2026) From 2D cultures to 3D systems: evolving cancer models at the interface of functional precision medicine and theranostics. Theranostics [Internet]. 16:4042 [cited 2026 Jun 7]; https:\/\/doi.org\/10.7150\/THNO.127053","DOI":"10.7150\/THNO.127053"},{"key":"12905_CR16","doi-asserted-by":"publisher","unstructured":"Nayak P, Bentivoglio V, Varani M, Signore A, Three-Dimensional (2023) In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates. Cancers (Basel) [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); [cited 2026 Jun 7];15:4846. https:\/\/doi.org\/10.3390\/CANCERS15194846","DOI":"10.3390\/CANCERS15194846"},{"key":"12905_CR17","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1021\/ACSBIOMATERIALS.2C00491\/SUPPL_FILE\/AB2C00491_SI_004.AVI","volume":"8","author":"AH Khan","year":"2022","unstructured":"Khan AH, Zhou SP, Moe M, Ortega Quesada BA, Bajgiran KR, Lassiter HR et al (2022) Generation of 3D Spheroids Using a Thiol-Acrylate Hydrogel Scaffold to Study Endocrine Response in ER+Breast Cancer. ACS Biomater Sci Eng [Internet], vol 8. American Chemical Society, pp 3977\u20133985. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1021\/ACSBIOMATERIALS.2C00491\/SUPPL_FILE\/AB2C00491_SI_004.AVI","journal-title":"ACS Biomater Sci Eng [Internet]"},{"key":"12905_CR18","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.3390\/IJMS24086949","volume":"24","author":"AG Mitrakas","year":"2023","unstructured":"Mitrakas AG, Tsolou A, Didaskalou S, Karkaletsou L, Efstathiou C, Eftalitsidis E et al (2023) Applications and Advances of Multicellular Tumor Spheroids: Challenges in Their Development and Analysis. Int J Mol Sci [Internet] 24:6949 [cited 2026 Jul 27]; https:\/\/doi.org\/10.3390\/IJMS24086949. Multidisciplinary Digital Publishing Institute (MDPI)","journal-title":"Int J Mol Sci [Internet]"},{"key":"12905_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/S12935-021-01853-8","volume":"21","author":"SJ Han","year":"2021","unstructured":"Han SJ, Kwon S, Kim KS (2021) Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int [Internet] BioMed Cent Ltd 21:152 [cited 2026 Jul 27]; https:\/\/doi.org\/10.1186\/S12935-021-01853-8","journal-title":"Cancer Cell Int [Internet] BioMed Cent Ltd"},{"key":"12905_CR20","doi-asserted-by":"publisher","unstructured":"Oishi K, Matsumoto K, Hashimoto S, Uchida F, Hara R, Nishimuta M et al (2025) Spheroid morphology of lung cancer cell lines correlates with oncological profiles. Discover Oncology 2025 16:1 [Internet]. Springer; [cited 2026 Jun 7];16:627. https:\/\/doi.org\/10.1007\/S12672-025-02132-Y","DOI":"10.1007\/S12672-025-02132-Y"},{"key":"12905_CR21","doi-asserted-by":"publisher","first-page":"100014","DOI":"10.1016\/J.MBM.2023.100014","volume":"1","author":"J He","year":"2023","unstructured":"He J, Zhang C, Ozkan A, Feng T, Duan P, Wang S et al (2023) Patient-derived tumor models and their distinctive applications in personalized drug therapy. Mechanobiol Med [Internet] Elsevier 1:100014 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1016\/J.MBM.2023.100014","journal-title":"Mechanobiol Med [Internet] Elsevier"},{"key":"12905_CR22","doi-asserted-by":"publisher","unstructured":"Shah S, D\u2019Souza GGM (2025) Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis. Cells [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); [cited 2026 Jun 7];14:732. https:\/\/doi.org\/10.3390\/CELLS14100732","DOI":"10.3390\/CELLS14100732"},{"key":"12905_CR23","doi-asserted-by":"publisher","unstructured":"Surina T, Suzuki T, Hisata S, Fujita K, Fujiwara S et al (2023) Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer. Heliyon [Internet], vol 9. Elsevier Ltd, p e13829. [cited 2026 Jul 27]; 10.1016\/J.HELIYON.2023.E13829 https:\/\/doi.org\/10.1016\/J.HELIYON.2023.E13829","DOI":"10.1016\/J.HELIYON.2023.E13829"},{"key":"12905_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/LIFEMEDI\/LNAF021","volume-title":"Whole-process 3D ECM-encapsulated organoid-based automated high-throughput screening platform accelerates drug discovery for rare diseases. Life Medicine [Internet]","author":"Z Xu","year":"2025","unstructured":"Xu Z, Yang H, Zhou Y, Dzakah EE, Zhao B (2025) Whole-process 3D ECM-encapsulated organoid-based automated high-throughput screening platform accelerates drug discovery for rare diseases. Life Medicine [Internet]. Oxford Academic. [cited 2026 Jun 9];4 https:\/\/doi.org\/10.1093\/LIFEMEDI\/LNAF021"},{"key":"12905_CR25","doi-asserted-by":"publisher","unstructured":"El Harane S, Zidi B, El Harane N, Krause KH, Matthes T, Preynat-Seauve O (2023) Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine. Cells [Internet]. MDPI; [cited 2026 Jun 7];12:1001. https:\/\/doi.org\/10.3390\/CELLS12071001","DOI":"10.3390\/CELLS12071001"},{"key":"12905_CR26","doi-asserted-by":"publisher","unstructured":"Gu X, Wei S, Lv X (2024) Circulating tumor cells: from new biological insights to clinical practice, vol 9. Nature Publishing Group, pp 226. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1038\/s41392-024-01938-6. Signal Transduction and Targeted Therapy 2024 9:1 [Internet]","DOI":"10.1038\/s41392-024-01938-6"},{"key":"12905_CR27","doi-asserted-by":"publisher","unstructured":"Mazloomi MA, Hamishehkar H, Jahanban Esfahlan R (2025) SpheroidSync as edge cutting transfer strategy for uniform and robust MCF7 spheroids in 3D culture. Scientific Reports 2025 15:1 [Internet]. Nature Publishing Group; [cited 2026 Jun 7];15:41237. https:\/\/doi.org\/10.1038\/s41598-025-25202-1","DOI":"10.1038\/s41598-025-25202-1"},{"key":"12905_CR28","doi-asserted-by":"publisher","first-page":"2400370","DOI":"10.1002\/ADTP.202400370","volume-title":"Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy. Adv Ther (Weinh) [Internet]","author":"N Desai","year":"2025","unstructured":"Desai N, Sahel D, Kubal B, Postwala H, Shah Y, Chavda VP et al (2025) Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy. Adv Ther (Weinh) [Internet], vol 8. John Wiley and Sons Inc, p 2400370. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1002\/ADTP.202400370 ;REQUESTEDJOURNAL:JOURNAL:23663987;WGROUP:STRING:PUBLICATION"},{"key":"12905_CR29","doi-asserted-by":"publisher","unstructured":"Cheng YS, Xu M, Chen G, Beers J, Chen CZ, Liu C et al (2023) A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells after Induction. Curr Protoc [Internet]. John Wiley and Sons Inc; [cited 2026 Jun 7];3:e866. https:\/\/doi.org\/10.1002\/CPZ1.866","DOI":"10.1002\/CPZ1.866"},{"key":"12905_CR30","doi-asserted-by":"publisher","unstructured":"Vitacolonna M, Bruch R, Schneider R, Jabs J, Hafner M, Reischl M et al (2024) A spheroid whole mount drug testing pipeline with machine-learning based image analysis identifies cell-type specific differences in drug efficacy on a single-cell level. BMC Cancer 2024 24:1 [Internet]. BioMed Central; [cited 2026 Jun 7];24:1542. https:\/\/doi.org\/10.1186\/S12885-024-13329-9","DOI":"10.1186\/S12885-024-13329-9"},{"key":"12905_CR31","doi-asserted-by":"publisher","unstructured":"Jeong Y, Tin A, Irudayaraj J (2022) Flipped Well-Plate Hanging-Drop Technique for Growing Three-Dimensional Tumors. Front Bioeng Biotechnol [Internet]. Frontiers Media S.A.; [cited 2026 Jun 7];10:898699. https:\/\/doi.org\/10.3389\/FBIOE.2022.898699\/TEXT","DOI":"10.3389\/FBIOE.2022.898699\/TEXT"},{"key":"12905_CR32","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.62347\/PPEI1766","volume":"17","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Huang S, Wu J, Liu P, Sun J, Xie X et al (2025) Spheroid culture of human periodontal ligament stem cells on agarose enhances stemness and osteogenic differentiation potential. Am J Transl Res [Internet] 17:5257 [cited 2026 Jun 7]; https:\/\/doi.org\/10.62347\/PPEI1766. e-Century Publishing Corporation","journal-title":"Am J Transl Res [Internet]"},{"key":"12905_CR33","doi-asserted-by":"publisher","unstructured":"Moshksayan K, Kashaninejad N, Warkiani ME, Lock JG, Moghadas H, Firoozabadi B et al (2018) Spheroids-on-a-chip: Recent advances and design considerations in microfluidic platforms for spheroid formation and culture. 263:151\u2013176 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.SNB.2018.01.223. Sens Actuators B Chem [Internet]","DOI":"10.1016\/J.SNB.2018.01.223"},{"key":"12905_CR34","doi-asserted-by":"publisher","unstructured":"Liu KC, Chen YC, Hsieh CF, Wang MH, Zhong MX, Cheng NC (2024) Scaffold-free 3D culture systems for stem cell-based tissue regeneration. APL Bioeng [Internet], vol 8. American Institute of Physics, p 041501. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1063\/5.0225807","DOI":"10.1063\/5.0225807"},{"key":"12905_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/MPS8050123\/S1","volume-title":"Standardized Methodology of Scaffold-Free and Scaffold-Based 3D Epithelial Spheroid Culture for Skin Regenerative Research","author":"MB de Ramos-Pinto","year":"2025","unstructured":"Ramos-Pinto MB, de Almeida Lan\u00e7a ML, Squarize CH, Castilho RM (2025) Standardized Methodology of Scaffold-Free and Scaffold-Based 3D Epithelial Spheroid Culture for Skin Regenerative Research. 8:123 [cited 2026 Jul 27]; https:\/\/doi.org\/10.3390\/MPS8050123\/S1. Methods Protoc [Internet]Multidisciplinary Digital Publishing Institute (MDPI)"},{"key":"12905_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/J.BIOACTMAT.2022.10.029","volume":"23","author":"F Wang","year":"2023","unstructured":"Wang F, Cai X, Shen Y, Meng L (2023) Cell\u2013scaffold interactions in tissue engineering for oral and craniofacial reconstruction. Bioact Mater [Internet] Elsevier 23:16\u201344 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1016\/J.BIOACTMAT.2022.10.029","journal-title":"Bioact Mater [Internet] Elsevier"},{"key":"12905_CR37","doi-asserted-by":"publisher","unstructured":"Idrisova KF, Simon HU, Gomzikova MO (2022) Role of Patient-Derived Models of Cancer in Translational Oncology. Cancers (Basel) [Internet]. 15:139 [cited 2026 Jul 27]; https:\/\/doi.org\/10.3390\/CANCERS15010139","DOI":"10.3390\/CANCERS15010139"},{"key":"12905_CR38","doi-asserted-by":"publisher","unstructured":"Ning K, Xie Y, Sun W, Feng L, Fang C, Pan R et al (2025) Non-destructive in situ monitoring of structural changes of 3D tumor spheroids during the formation, migration, and fusion process. Elife [Internet], vol 13. eLife Sciences Publications, Ltd, p RP101886. [cited 2026 Jun 7]; https:\/\/doi.org\/10.7554\/ELIFE.101886","DOI":"10.7554\/ELIFE.101886"},{"key":"12905_CR39","doi-asserted-by":"publisher","unstructured":"Griffin KH, Fok SW, Kent Leach J (2022) Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling. npj Regenerative Medicine 2022 7:1 [Internet]. Nature Publishing Group; [cited 2026 Jun 7];7:70. https:\/\/doi.org\/10.1038\/s41536-022-00266-z","DOI":"10.1038\/s41536-022-00266-z"},{"key":"12905_CR40","doi-asserted-by":"publisher","unstructured":"Mangani S, Kremmydas S, Karamanos NK (2025) Mimicking the Complexity of Solid Tumors: How Spheroids Could Advance Cancer Preclinical Transformative Approaches. Cancers (Basel) [Internet]. 17:1161 [cited 2026 Jun 7]; https:\/\/doi.org\/10.3390\/CANCERS17071161. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/CANCERS17071161"},{"key":"12905_CR41","doi-asserted-by":"publisher","unstructured":"Gunti S, Hoke ATK, Vu KP, London NR (2021) Organoid and Spheroid Tumor Models: Techniques and Applications. Cancers (Basel) [Internet], vol 13. MDPI AG, p 874. [cited 2026 Jun 7]; https:\/\/doi.org\/10.3390\/CANCERS13040874","DOI":"10.3390\/CANCERS13040874"},{"key":"12905_CR42","doi-asserted-by":"publisher","unstructured":"Hu J, Liu K, Ghosh C, Khaket TP, Shih H, Kebebew E (2024) Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics. J Exp Clin Cancer Res [Internet]. BioMed Central Ltd; [cited 2026 Jun 7];43:85. https:\/\/doi.org\/10.1186\/S13046-024-03009-8","DOI":"10.1186\/S13046-024-03009-8"},{"key":"12905_CR43","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1016\/J.CSBJ.2025.11.067","volume":"27","author":"D Okyere","year":"2025","unstructured":"Okyere D, Bravo-Merodio L, Xu Y, Guan X, Parkhi D, Gkoutos G et al (2025) Drug response in the era of precision medicine: A methodological review. Comput Struct Biotechnol J [Internet] Elsevier B V 27:5503 [cited 2026 Jul 27]; https:\/\/doi.org\/10.1016\/J.CSBJ.2025.11.067","journal-title":"Comput Struct Biotechnol J [Internet] Elsevier B V"},{"key":"12905_CR44","doi-asserted-by":"publisher","unstructured":"Kundu S, Tripathi R, Mehta A, Singh A, Khanna A, Rawal SK (2026) Integrative multi-omics analysis identifies histone methyltransferase SUV420H2 as a prognostic biomarker in clear cell renal cell carcinoma. Springer. [cited 2026 Sep 29]; https:\/\/doi.org\/10.1007\/S12672-026-05556-2. Discover Oncology 2026 [Internet]","DOI":"10.1007\/S12672-026-05556-2"},{"key":"12905_CR45","doi-asserted-by":"publisher","unstructured":"Jeon H, Kim G, Carpenter J, Col\u00f3n YJ, Wang Y, Automated High-Content (2025) High-Throughput Spatial Analysis Pipeline for Drug Screening in 3D Tumor Spheroid Inverted Colloidal Crystal Arrays. ACS Appl Mater Interfaces [Internet]. American Chemical Society; [cited 2026 Jun 7];17:49210\u201349226. https:\/\/doi.org\/10.1021\/ACSAMI.5C10049","DOI":"10.1021\/ACSAMI.5C10049"},{"key":"12905_CR46","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1038\/S41467-025-66269-8","volume":"16","author":"MB Avci","year":"2025","unstructured":"Avci MB, Kocer F, Kurul F, Cetin AE (2025) An integrated platform for liquid handling and cell imaging in life science applications. Nat Commun [Internet] Nat Res 16:11521 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1038\/S41467-025-66269-8","journal-title":"Nat Commun [Internet] Nat Res"},{"key":"12905_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/S43856-025-01359-8","volume":"6","author":"B Haspels","year":"2026","unstructured":"Haspels B, Paul MW, Jagessar Tewari J, Bavelaar M, Komar ZM, Jonkers J et al (2026) High-throughput spheroid-based assay for functional breast cancer precision medicine facilitated by deep learning. Commun Med [Internet] Springer Sci Bus Media LLC 6:94 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1038\/S43856-025-01359-8","journal-title":"Commun Med [Internet] Springer Sci Bus Media LLC"},{"key":"12905_CR48","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.3390\/IJMS26136478","volume":"26","author":"KM Lonkwic","year":"2025","unstructured":"Lonkwic KM, Zajdel R, Kaczka K (2025) Unlocking the Potential of Spheroids in Personalized Medicine: A Systematic Review of Seeding Methodologies. Int J Mol Sci [Internet] 26:6478 [cited 2026 Jun 7]; https:\/\/doi.org\/10.3390\/IJMS26136478. Multidisciplinary Digital Publishing Institute (MDPI)","journal-title":"Int J Mol Sci [Internet]"},{"key":"12905_CR49","doi-asserted-by":"publisher","unstructured":"Lonkwic KM, Zajdel R, Kaczka K (2025) Unlocking the Potential of Spheroids in Personalized Medicine: A Systematic Review of Seeding Methodologies. International Journal of Molecular Sciences. Vol 26, Page 6478 [Internet]. Multidisciplinary Digital Publishing Institute; 2025 [cited 2026 Jun 7];26:6478. https:\/\/doi.org\/10.3390\/IJMS26136478","DOI":"10.3390\/IJMS26136478"},{"key":"12905_CR50","doi-asserted-by":"publisher","first-page":"100003","DOI":"10.1016\/J.NAMJNL.2024.100003","volume":"1","author":"SUN A M AV","year":"2025","unstructured":"A M AV SUN, Kumar VR, Parthasarathy TT (2025) New frontiers in anti-cancer drug testing: The need for a relevant In vitro testing model. NAM J [Internet] Elsevier 1:100003 [cited 2026 Jun 7]; https:\/\/doi.org\/10.1016\/J.NAMJNL.2024.100003","journal-title":"NAM J [Internet] Elsevier"},{"key":"12905_CR51","doi-asserted-by":"publisher","unstructured":"Kundu S, Jit BP, Sharma A (2024) Pan-cancer TCGA analysis reveals the potential involvement of B-type lamins in dysregulating chromosome segregation in human cancer. Mammalian Genome 2024 36:1 [Internet]. Springer; [cited 2026 Mar 23];36:230\u201349. https:\/\/doi.org\/10.1007\/s00335-024-10086-9","DOI":"10.1007\/s00335-024-10086-9"},{"key":"12905_CR52","doi-asserted-by":"publisher","first-page":"1545017","DOI":"10.3389\/FGENE.2025.1545017\/FULL","volume":"16","author":"V Hanitrarimalala","year":"2025","unstructured":"Hanitrarimalala V, Prgomet Z, Hedhammar M, Tassidis H, Wingren AG (2025) In vitro 3D modeling of colorectal cancer: the pivotal role of the extracellular matrix, stroma and immune modulation. Front Genet Front Media SA 16:1545017. https:\/\/doi.org\/10.3389\/FGENE.2025.1545017\/FULL","journal-title":"Front Genet Front Media SA"},{"key":"12905_CR53","doi-asserted-by":"publisher","unstructured":"Zawawi SSA, Salleh EA, Musa M (2024) Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening. Explor Target Antitumor Ther [Internet], vol 5. Open Exploration Publishing Inc, p 409. [cited 2026 Jun 7]; https:\/\/doi.org\/10.37349\/ETAT.2024.00226","DOI":"10.37349\/ETAT.2024.00226"},{"key":"12905_CR54","doi-asserted-by":"publisher","unstructured":"Qiu X, Li R, Zhou J, Li P, Xie G, Yin S et al (2025) Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters. Transl Oncol [Internet]. Elsevier; [cited 2026 Jun 7];61:102518. https:\/\/doi.org\/10.1016\/J.TRANON.2025.102518","DOI":"10.1016\/J.TRANON.2025.102518"},{"key":"12905_CR55","doi-asserted-by":"publisher","unstructured":"Motohashi S, Katsuta E, Ban D (2025) Advances and Challenges in Drug Screening for Cancer Therapy: A Comprehensive Review. Bioengineering 2025, vol 12. Multidisciplinary Digital Publishing Institute, p 1315. [cited 2026 Jun 7]; https:\/\/doi.org\/10.3390\/BIOENGINEERING12121315. Page 1315 [Internet]","DOI":"10.3390\/BIOENGINEERING12121315"},{"key":"12905_CR56","doi-asserted-by":"publisher","unstructured":"Lamichhane A, Thakuri PS, Rafsanjani Nejad P, Tavana H (2021) Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids. Exp Biol Med [Internet], vol 246. SAGE Publications Inc., p 2372. [cited 2026 Jun 7]; https:\/\/doi.org\/10.1177\/15353702211014185","DOI":"10.1177\/15353702211014185"},{"key":"12905_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/S10142-026-02030-8","author":"D Chakraborty","year":"2026","unstructured":"Chakraborty D, Kundu S, Gupta V, Patel M, Rawal SK, Mani S (2026) Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer. Funct Integr Genomics [Internet] Funct Integr Genomics. [cited 2026 Sep 29];26 https:\/\/doi.org\/10.1007\/S10142-026-02030-8","journal-title":"Funct Integr Genomics [Internet] Funct Integr Genomics"},{"key":"12905_CR58","doi-asserted-by":"publisher","unstructured":"Lee KH, Kim TH (2021) Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening. Biosensors (Basel) [Internet]. 11:445 [cited 2026 Jun 8]; https:\/\/doi.org\/10.3390\/BIOS11110445","DOI":"10.3390\/BIOS11110445"},{"key":"12905_CR59","doi-asserted-by":"publisher","first-page":"27449","DOI":"10.1038\/S41598-025-12556-9","volume":"15","author":"O Piwocka","year":"2025","unstructured":"Piwocka O, Sterzy\u0144ska K, Mali\u0144ska A, Suchorska WM, Kulcenty K (2025) Development of tetraculture spheroids as a versatile 3D model for personalized breast cancer research. Sci Rep [Internet] Nat Res 15:27449 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1038\/S41598-025-12556-9","journal-title":"Sci Rep [Internet] Nat Res"},{"key":"12905_CR60","doi-asserted-by":"publisher","unstructured":"Hofmann S, Cohen-Harazi R, Maizels Y, Koman I (2022) Patient-derived tumor spheroid cultures as a promising tool to assist personalized therapeutic decisions in breast cancer. Transl Cancer Res [Internet], vol 11. AME Publishing Company, pp 134\u2013147. [cited 2026 Jun 8]; https:\/\/doi.org\/10.21037\/TCR-21-1577\/COIF","DOI":"10.21037\/TCR-21-1577\/COIF"},{"key":"12905_CR61","doi-asserted-by":"publisher","unstructured":"Chen X, Sifakis EG, Robertson S, Neo SY, Jun SH, Tong L et al (2022) Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction. Proc Natl Acad Sci U S A [Internet]. National Academy of Sciences; [cited 2026 Jun 8];120:e2209856120. https:\/\/doi.org\/10.1073\/PNAS.2209856120","DOI":"10.1073\/PNAS.2209856120"},{"key":"12905_CR62","doi-asserted-by":"publisher","unstructured":"Chen S, Chen W, Guan Z, Lei L, Lei Y, Tang K et al (2025) Development of a 3D-3 co-culture microbead consisting of cancer-associated fibroblasts and human umbilical vein endothelial cells for the anti-tumor drug assessment of lung cancer. Transl Lung Cancer Res [Internet]. 14:2159\u20132179 [cited 2026 Jun 9]; https:\/\/doi.org\/10.21037\/TLCR-2025-525\/COIF. AME Publishing Company","DOI":"10.21037\/TLCR-2025-525\/COIF"},{"key":"12905_CR63","doi-asserted-by":"publisher","unstructured":"Balachander GM, Kotcherlakota R, Nayak B, Kedaria D, Rangarajan A, Chatterjee K (2021) 3D Tumor Models for Breast Cancer: Whither We Are and What We Need, vol 7. American Chemical Society, pp 3470\u20133486. [cited 2026 Jun 8]; https:\/\/doi.org\/10.1021\/ACSBIOMATERIALS.1C00230. ACS Biomater Sci Eng [Internet]","DOI":"10.1021\/ACSBIOMATERIALS.1C00230"},{"key":"12905_CR64","doi-asserted-by":"publisher","unstructured":"Hong CE, Lyu SY (2025) Formulation Strategies for Immunomodulatory Natural Products in 3D Tumor Spheroids and Organoids: Current Challenges and Emerging Solutions. Pharmaceutics 2025, vol 17. Multidisciplinary Digital Publishing Institute, p 1258. [cited 2026 Jun 8]; https:\/\/doi.org\/10.3390\/PHARMACEUTICS17101258 Page 1258 [Internet]","DOI":"10.3390\/PHARMACEUTICS17101258"},{"key":"12905_CR65","doi-asserted-by":"publisher","unstructured":"Alatawi H, Nair HH, Raza A, Velez E, Sharma AK, Narayan S (2026) Human-Centric Modeling in Metastatic Breast Cancer: Organoids, Organ-on-Chip Systems, and New Approach Methodologies in the Post-FDA Modernization Act 2.0 Era. Cancers (Basel) [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); [cited 2026 Jun 8];18:1166. https:\/\/doi.org\/10.3390\/CANCERS18071166","DOI":"10.3390\/CANCERS18071166"},{"key":"12905_CR66","doi-asserted-by":"publisher","unstructured":"Es HA, Cox TR, Sarafraz-Yazdi E, Thiery JP, Warkiani ME (2021) Pirfenidone Reduces Epithelial\u2013Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs). Cancers 2021, vol 13. Multidisciplinary Digital Publishing Institute, p 5118. [cited 2026 Jun 9]; https:\/\/doi.org\/10.3390\/CANCERS13205118 Page 5118 [Internet]","DOI":"10.3390\/CANCERS13205118"},{"key":"12905_CR67","doi-asserted-by":"publisher","unstructured":"Khan S, Jandrajupalli SB, Bushara NZA, Raja RDP, Mirza S, Sharma K et al (2024) Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine. Cells [Internet]. [cited 2026 Jun 9];13 https:\/\/doi.org\/10.3390\/CELLS13242126","DOI":"10.3390\/CELLS13242126"},{"key":"12905_CR68","doi-asserted-by":"publisher","unstructured":"Tay AHM, Prieto-D\u00edaz R, Neo S, Tong L, Chen X, Carannante V et al (2022) A2B adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models. J Immunother Cancer [Internet]. BMJ Publishing Group Ltd; [cited 2026 Jun 9];10:4592. https:\/\/doi.org\/10.1136\/JITC-2022-004592","DOI":"10.1136\/JITC-2022-004592"},{"key":"12905_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/FBIOE.2023.1159819","author":"M Rodriguez-Perdigon","year":"2023","unstructured":"Rodriguez-Perdigon M, Haeni L, Rothen-Rutishauser B, R\u00fcegg C (2023) Dual CSF1R inhibition and CD40 activation demonstrates anti-tumor activity in a 3D macrophage- HER2\u2009+\u2009breast cancer spheroid model. Front Bioeng Biotechnol [Internet] Front Bioeng Biotechnol. [cited 2026 Jun 9];11 https:\/\/doi.org\/10.3389\/FBIOE.2023.1159819","journal-title":"Front Bioeng Biotechnol [Internet] Front Bioeng Biotechnol"},{"key":"12905_CR70","doi-asserted-by":"publisher","unstructured":"Velletri T, Villa CE, Cilli D, Barzaghi B, Lo Riso P, Lupia M et al (2021) Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer. Cell Death & Differentiation 2021 29:3 [Internet]. Nature Publishing Group; [cited 2026 Jun 9];29:614\u201326. https:\/\/doi.org\/10.1038\/s41418-021-00878-w","DOI":"10.1038\/s41418-021-00878-w"},{"key":"12905_CR71","doi-asserted-by":"publisher","unstructured":"Jiang YX, Siu MKY, Wang JJ, Mo XT, Leung THY, Chan DW et al (2020) Ascites-derived ALDH+CD44\u2009+\u2009tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3\/AKT\/NF-\u03baB\/IL-8 signalling in ovarian cancer. Br J Cancer [Internet]. Springer Nature; [cited 2026 Jun 9];123:275\u201387. https:\/\/doi.org\/10.1038\/S41416-020-0865-Z;SUBJMETA","DOI":"10.1038\/S41416-020-0865-Z;SUBJMETA"},{"key":"12905_CR72","doi-asserted-by":"publisher","unstructured":"Alizadeh H, Akbarabadi P, Dadfar A, Tareh MR, Soltani B (2025) A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities. Molecular Cancer 2025 24:1 [Internet]. BioMed Central; [cited 2026 Jun 9];24:135. https:\/\/doi.org\/10.1186\/S12943-025-02345-3","DOI":"10.1186\/S12943-025-02345-3"},{"key":"12905_CR73","doi-asserted-by":"publisher","unstructured":"Shuford S, Wilhelm C, Rayner M, Elrod A, Millard M, Mattingly C et al (2019) Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer. Sci Rep [Internet], vol 9. Nature Publishing Group, p 11153. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1038\/S41598-019-47578-7","DOI":"10.1038\/S41598-019-47578-7"},{"key":"12905_CR74","doi-asserted-by":"publisher","unstructured":"Napoli GC, Figg WD, Chau CH, Frontiers Media SA (2022) [cited 2026 Jun 9];9:912641. https:\/\/doi.org\/10.3389\/FMED.2022.912641","DOI":"10.3389\/FMED.2022.912641"},{"key":"12905_CR75","doi-asserted-by":"publisher","unstructured":"Ford CE, Werner B, Hacker NF, Warton K (2020) The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer [Internet]. Springer Nature; [cited 2026 Jun 9];123:9. https:\/\/doi.org\/10.1038\/S41416-020-0875-X","DOI":"10.1038\/S41416-020-0875-X"},{"key":"12905_CR76","doi-asserted-by":"publisher","unstructured":"Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP et al (2022) Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers (Basel) [Internet]. 14:958 [cited 2026 Jun 9]; https:\/\/doi.org\/10.3390\/CANCERS14040958. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/CANCERS14040958"},{"key":"12905_CR77","doi-asserted-by":"publisher","unstructured":"Raghavan S, Mehta P, Ward MR, Bregenzer ME, Fleck EMA, Tan L et al (2017) Personalized Medicine Based Approach to Model Patterns of Chemoresistance, and Tumor Recurrence Using Ovarian Cancer Stem Cell Spheroids. Clin Cancer Res [Internet]. American Association for Cancer Research Inc.; [cited 2026 Jun 9];23:6934. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0133","DOI":"10.1158\/1078-0432.CCR-17-0133"},{"key":"12905_CR78","doi-asserted-by":"publisher","unstructured":"Yamawaki K, Mori Y, Sakai H, Kanda Y, Shiokawa D, Ueda H et al (2021) Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance. Cancer Lett [Internet], vol 521. Elsevier Ireland Ltd, pp 29\u201338. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/j.canlet.2021.08.018","DOI":"10.1016\/j.canlet.2021.08.018"},{"key":"12905_CR79","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/S00262-021-02849-Z","volume":"70","author":"KM Appleton","year":"2021","unstructured":"Appleton KM, Elrod AK, Lassahn KA, Shuford S, Holmes LM, DesRochers TM (2021) PD-1\/PD-L1 checkpoint inhibitors in combination with olaparib display antitumor activity in ovarian cancer patient-derived three-dimensional spheroid cultures. Cancer Immunol Immunother [Internet] Cancer Immunol Immunother 70:843\u2013856 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1007\/S00262-021-02849-Z","journal-title":"Cancer Immunol Immunother [Internet] Cancer Immunol Immunother"},{"key":"12905_CR80","doi-asserted-by":"publisher","unstructured":"Karimnia N, Wilson AL, Doran BR, Do J, Matthews A, Ho GY, Sons Inc (2025) A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer. Adv Healthc Mater [Internet]. John Wiley and ; [cited 2026 Jun 9];14:2404117. https:\/\/doi.org\/10.1002\/ADHM.202404117","DOI":"10.1002\/ADHM.202404117"},{"key":"12905_CR81","doi-asserted-by":"publisher","unstructured":"Evangelista A, Scocozza F, Conti M, Auricchio F, Conti B, Dorati R et al (2025) Exploring Mechanical Features of 3D Head and Neck Cancer Models. 16:74 [cited 2026 Jun 9];. 10.3390\/JFB16030074 https:\/\/doi.org\/10.3390\/JFB16030074. J Funct Biomater [Internet]Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/JFB16030074"},{"key":"12905_CR82","doi-asserted-by":"publisher","unstructured":"Parikh AS, Yu VX, Flashner S, Okolo OB, Lu C, Henick BS et al (2023) Patient-Derived Three-Dimensional Culture Techniques to Model Tumor Heterogeneity in Head and Neck Cancer. Oral Oncol [Internet], vol 138. Elsevier Ltd, p 106330. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2023.106330","DOI":"10.1016\/J.ORALONCOLOGY.2023.106330"},{"key":"12905_CR83","doi-asserted-by":"publisher","unstructured":"Bhatia A, Mehra R, Bauman J, Khan SA, Wei W, Neumeister V et al (2025) Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck. Head Neck [Internet]. 47:2373\u20132382 [cited 2026 Jun 9]. https:\/\/doi.org\/10.1002\/HED.28152. Head Neck","DOI":"10.1002\/HED.28152"},{"key":"12905_CR84","doi-asserted-by":"publisher","unstructured":"van Aken ESM, Gandhi AK, O\u2019Cathail SM, Borst G, Barriuso J, Fokas E et al (2026) ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4\/6, HER2, PARP, or mTOR inhibitors. 215:111330 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.RADONC.2025.111330. Radiotherapy and Oncology [Internet]","DOI":"10.1016\/J.RADONC.2025.111330"},{"key":"12905_CR85","doi-asserted-by":"publisher","first-page":"960340","DOI":"10.3389\/FONC.2022.960340\/FULL","volume":"12","author":"CR Moya-Garcia","year":"2022","unstructured":"Moya-Garcia CR, Okuyama H, Sadeghi N, Li J, Tabrizian M, Li-Jessen NYK (2022) In vitro models for head and neck cancer: Current status and future perspective. Front Oncol Front Media S A 12:960340. https:\/\/doi.org\/10.3389\/FONC.2022.960340\/FULL","journal-title":"Front Oncol Front Media S A"},{"key":"12905_CR86","doi-asserted-by":"publisher","first-page":"100590","DOI":"10.1016\/J.CTRO.2023.100590","volume-title":"Artificial intelligence to predict outcomes of head and neck radiotherapy","author":"C Bang","year":"2023","unstructured":"Bang C, Bernard G, Le WT, Lalonde A, Kadoury S, Bahig H (2023) Artificial intelligence to predict outcomes of head and neck radiotherapy, vol 39. Elsevier Ireland Ltd, p 100590. [cited 2026 Jun 9]; 10.1016\/J.CTRO.2023.100590 https:\/\/doi.org\/10.1016\/J.CTRO.2023.100590. Clin Transl Radiat Oncol [Internet]"},{"key":"12905_CR87","doi-asserted-by":"publisher","first-page":"107814","DOI":"10.1016\/J.ORALONCOLOGY.2025.107814","volume":"172","author":"HN Yoon","year":"2026","unstructured":"Yoon HN, Kim Jha, Gu D, Lee J, Kim SY, Kim HJ et al (2026) Patient-derived 3D organoid platform for functional assessment of GPC3-targeted CAR T cell cytotoxic activity in head and neck squamous cell carcinoma. Oral Oncol [Internet] Pergamon 172:107814 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2025.107814","journal-title":"Oral Oncol [Internet] Pergamon"},{"key":"12905_CR88","doi-asserted-by":"publisher","unstructured":"L\u00ea H, Seitlinger J, Lindner V, Olland A, Falcoz PE, Benkirane-Jessel N et al (2022) Patient-Derived Lung Tumoroids\u2014An Emerging Technology in Drug Development and Precision Medicine. Biomedicines [Internet]. 10:1677 [cited 2026 Jun 9]; https:\/\/doi.org\/10.3390\/BIOMEDICINES10071677","DOI":"10.3390\/BIOMEDICINES10071677"},{"key":"12905_CR89","doi-asserted-by":"publisher","first-page":"1293441","DOI":"10.3389\/FONC.2023.1293441\/FULL","volume":"13","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhou Y, Chen P (2023) Lung cancer organoids: models for preclinical research and precision medicine. Front Oncol Front Media SA 13:1293441. https:\/\/doi.org\/10.3389\/FONC.2023.1293441\/FULL","journal-title":"Front Oncol Front Media SA"},{"key":"12905_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/J.LDDD.2026.100424","volume-title":"Organoid models in lung cancer research: A multidimensional perspective from basic biology to precision medicine","author":"R Zhao","year":"2026","unstructured":"Zhao R, Cheng H, Mei S, Li H, Zhang L, Li Y (2026) Organoid models in lung cancer research: A multidimensional perspective from basic biology to precision medicine. Elsevier. [cited 2026 Jun 9];100424 10.1016\/J.LDDD.2026.100424 https:\/\/doi.org\/10.1016\/J.LDDD.2026.100424. Lett Drug Des Discov [Internet]"},{"key":"12905_CR91","doi-asserted-by":"publisher","first-page":"1387345","DOI":"10.3389\/FONC.2024.1387345","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhang Y, Zhu Y, Dong T, Liu Z (2024) Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives. Front Oncol [Internet] Front Media SA 14:1387345 [cited 2026 Jun 9];. https:\/\/doi.org\/10.3389\/FONC.2024.1387345","journal-title":"Front Oncol [Internet] Front Media SA"},{"key":"12905_CR92","doi-asserted-by":"publisher","unstructured":"Garg P, Pareek S, Kulkarni P, Horne D, Salgia R, Singhal SS (2024) Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment. 13:6537 [cited 2026 Jun 9]; 10.3390\/JCM13216537 https:\/\/doi.org\/10.3390\/JCM13216537. J Clin Med [Internet]Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/JCM13216537"},{"key":"12905_CR93","doi-asserted-by":"publisher","first-page":"116595","DOI":"10.1016\/J.CELREP.2025.116595","volume":"44","author":"H Terai","year":"2025","unstructured":"Terai H, Yasuda H, Sato T (2025) Organoid-based precision cancer modeling: New frontier in lung cancer research. Cell Rep [Internet] Cell Press 44:116595 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.CELREP.2025.116595","journal-title":"Cell Rep [Internet] Cell Press"},{"key":"12905_CR94","doi-asserted-by":"publisher","first-page":"1634413","DOI":"10.3389\/FPHAR.2025.1634413\/FULL","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Fu Y, Bai G, Qiu J, Hua K (2025) Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming. Front Pharmacol Front Media SA 16:1634413. https:\/\/doi.org\/10.3389\/FPHAR.2025.1634413\/FULL","journal-title":"Front Pharmacol Front Media SA"},{"key":"12905_CR95","doi-asserted-by":"publisher","unstructured":"Castro LM, Paiva L, Lobo I, Neves AR, Albuquerque T, Sousa \u00c2 et al (2026) Modeling 3D Glioblastoma: A review of spheroid culture techniques and standardization challenges. Methods [Internet]. Academic Press; [cited 2026 Jun 9];253:129\u201341. https:\/\/doi.org\/10.1016\/J.YMETH.2026.05.013","DOI":"10.1016\/J.YMETH.2026.05.013"},{"key":"12905_CR96","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/S11912-025-01672-4","volume-title":"Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening","author":"G Thomas","year":"2025","unstructured":"Thomas G, Rahman R (2025) Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening, vol 27. Springer, p 601. [cited 2026 Jun 9] https:\/\/doi.org\/10.1007\/S11912-025-01672-4. Curr Oncol Rep [Internet]"},{"key":"12905_CR97","doi-asserted-by":"publisher","unstructured":"Jezierza\u0144ski M, Nafalska N, Stopyra M, Furgo\u0142 T, Miciak M, Kabut J et al (2024) Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme\u2014A Literature Review and Clinical Outcomes. Current Oncology [Internet]. 31:3994 [cited 2026 Jun 9]; https:\/\/doi.org\/10.3390\/CURRONCOL31070296. Multidisciplinary Digital Publishing Institute (MDPI)","DOI":"10.3390\/CURRONCOL31070296"},{"key":"12905_CR98","doi-asserted-by":"publisher","unstructured":"Beylerli O, Gareev I, Musaev E, Roumiantsev S, Chekhonin V, Ahmad A et al (2025) New approaches to targeted drug therapy of intracranial tumors. Cell Death Discov [Internet]. Springer Nature; [cited 2026 Jun 9];11:111. https:\/\/doi.org\/10.1038\/S41420-025-02358-3","DOI":"10.1038\/S41420-025-02358-3"},{"key":"12905_CR99","doi-asserted-by":"publisher","unstructured":"Azeez SS, Yashooa RK, Smail SW, Salihi A, Ali AS, Mamand S et al (2025) Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives. Molecular Cancer 2025 24:1 [Internet]. BioMed Central; [cited 2026 Jun 9];24:191. https:\/\/doi.org\/10.1186\/S12943-025-02386-8","DOI":"10.1186\/S12943-025-02386-8"},{"key":"12905_CR100","doi-asserted-by":"publisher","unstructured":"Stojanov SJ, Grozdani\u0107 M, Ljuji\u0107 M, Dragi\u010devi\u0107 S, Dragoj M, Dini\u0107 J (2025) Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance. Oncol Res [Internet], vol 33. Tech Science, pp 2741\u20132785. [cited 2026 Jun 9]; https:\/\/doi.org\/10.32604\/OR.2025.067126","DOI":"10.32604\/OR.2025.067126"},{"key":"12905_CR101","doi-asserted-by":"publisher","unstructured":"Thomas G, Rahman R (2025) Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening, vol 27. Springer, pp 601\u2013624. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1007\/S11912-025-01672-4. Current Oncology Reports 2025 27:5 [Internet]","DOI":"10.1007\/S11912-025-01672-4"},{"key":"12905_CR102","doi-asserted-by":"publisher","unstructured":"CE C-C QL (2012) A G, A P, K S. Three-Dimensional Cell Culture Models for Biomarker Discoveries and Cancer Research. Translational Medicine [Internet]. Longdom Publishing S.L; [cited 2026 Jun 9];0:1\u20138. https:\/\/doi.org\/10.4172\/2161-1025.S1-005","DOI":"10.4172\/2161-1025.S1-005"},{"key":"12905_CR103","doi-asserted-by":"publisher","DOI":"10.1007\/S12026-026-09806-X","author":"D Chakraborty","year":"2026","unstructured":"Chakraborty D, Kundu S, Rawal SK, Mani S (2026) Emerging target antigen landscape for CAR T-cell therapy in solid tumors: current advances and future directions. Immunol Res [Internet] Immunol Res. [cited 2026 Sep 29];74 https:\/\/doi.org\/10.1007\/S12026-026-09806-X","journal-title":"Immunol Res [Internet] Immunol Res"},{"key":"12905_CR104","doi-asserted-by":"publisher","unstructured":"Shetty S, Kumar NAN, Kabekkodu SP, Chakrabarty S (2026) A comprehensive review of microfluidic-based organ-on-chip technology in the application of preclinical drug discovery studies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer [Internet], vol 1881. Elsevier, p 189627. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1016\/J.BBCAN.2026.189627","DOI":"10.1016\/J.BBCAN.2026.189627"},{"key":"12905_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/S41586-020-2099-X","volume":"580","author":"K Han","year":"2020","unstructured":"Han K, Pierce SE, Li A, Spees K, Anderson GR, Seoane JA et al (2020) CRISPR screens in cancer spheroids identify 3D growth specific vulnerabilities. Nat [Internet] Nat Res 580:136 [cited 2026 Jun 9]; https:\/\/doi.org\/10.1038\/S41586-020-2099-X","journal-title":"Nat [Internet] Nat Res"},{"key":"12905_CR106","doi-asserted-by":"publisher","unstructured":"Abdurakhmanova MM, Leonteva AA, Vasilieva NS, Kuligina EV, Nushtaeva AA 3D cell culture models: how to obtain and characterize the main models. Vavilov Journal of Genetics and Breeding [Internet]. Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences; 2025 [cited 2026 Jul 27];29:175. https:\/\/doi.org\/10.18699\/VJGB-25-21","DOI":"10.18699\/VJGB-25-21"},{"key":"12905_CR107","doi-asserted-by":"publisher","unstructured":"Ishiguro T, Ohata H, Sato A, Yamawaki K, Enomoto T, Okamoto K (2017) Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications. Cancer Sci [Internet]. Blackwell Publishing Ltd; [cited 2026 Jul 27];108:283. https:\/\/doi.org\/10.1111\/CAS.13155","DOI":"10.1111\/CAS.13155"},{"key":"12905_CR108","doi-asserted-by":"publisher","unstructured":"Stojanov SJ, Grozdani\u0107 M, Ljuji\u0107 M, Dragi\u010devi\u0107 S, Dragoj M, Dini\u0107 J (2025) Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance. Oncol Res [Internet], vol 33. Tech Science, p 2741. [cited 2026 Jul 27]; https:\/\/doi.org\/10.32604\/OR.2025.067126","DOI":"10.32604\/OR.2025.067126"},{"key":"12905_CR109","doi-asserted-by":"publisher","unstructured":"Zhang J, He J (2026) Organoid technology in cancer research. Molecular Biomedicine. 7:1 [Internet]. Springer; 2026 [cited 2026 Jul 27];7:103. https:\/\/doi.org\/10.1186\/S43556-026-00505-5","DOI":"10.1186\/S43556-026-00505-5"},{"key":"12905_CR110","doi-asserted-by":"publisher","unstructured":"Zhao Z, Chen X, Dowbaj AM, Sljukic A, Bratlie K, Lin L et al (2022) Organoids. Nature reviews Methods primers [Internet], vol 2. Springer Nature, p 94. [cited 2026 Jul 27]; https:\/\/doi.org\/10.1038\/S43586-022-00174-Y","DOI":"10.1038\/S43586-022-00174-Y"},{"key":"12905_CR111","doi-asserted-by":"publisher","unstructured":"Zhu S, Yin J, Lu X, Jiang D, Chen R, Cui K et al Influence of experimental variables on spheroid attributes. [cited 2026 Jun 9]; https:\/\/doi.org\/10.1038\/s41598-025-92037-1","DOI":"10.1038\/s41598-025-92037-1"},{"key":"12905_CR112","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8347595","author":"AT Serra","year":"2019","unstructured":"Serra AT, Serra M, Silva AC, Brckalo T, Seshire A, Brito C et al (2019) Scalable Culture Strategies for the Expansion of Patient-Derived Cancer Stem Cell Lines. Stem Cells Int [Internet] Hindawi Ltd 8347595 [cited 2026 Jun 9];2019:. https:\/\/doi.org\/10.1155\/2019\/8347595","journal-title":"Stem Cells Int [Internet] Hindawi Ltd"},{"key":"12905_CR113","doi-asserted-by":"publisher","unstructured":"Jeong SR, Kang M (2023) Exploring Tumor\u2013Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients. International Journal of Molecular Sciences. Vol 24, Page 14609 [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 Jun 9];24:14609. https:\/\/doi.org\/10.3390\/IJMS241914609","DOI":"10.3390\/IJMS241914609"},{"key":"12905_CR114","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/JBM.S36134","volume-title":"Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives","author":"C Petrini","year":"2012","unstructured":"Petrini C (2012) Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives, vol 3. Dove Medical Press Ltd., p 87. [cited 2026 Jun 9]; https:\/\/doi.org\/10.2147\/JBM.S36134. J Blood Med [Internet]"},{"key":"12905_CR115","doi-asserted-by":"publisher","unstructured":"Nayak P, Bentivoglio V, Varani M, Signore A, Three-Dimensional (2023) In Vitro Tumor Spheroid Models for Evaluation of Anticancer Therapy: Recent Updates. Cancers (Basel) [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); [cited 2026 Jun 9];15:4846. https:\/\/doi.org\/10.3390\/CANCERS15194846","DOI":"10.3390\/CANCERS15194846"},{"key":"12905_CR116","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/BIOS14080392\/S1","volume-title":"Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process. Biosensors (Basel) [Internet]","author":"KCC Pong","year":"2024","unstructured":"Pong KCC, Lai YS, Wong RCH, Lee ACK, Chow SCT, Lam JCW et al (2024) Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process. Biosensors (Basel) [Internet], vol 14. Multidisciplinary Digital Publishing Institute (MDPI), p 392. [cited 2026 Jun 9]; https:\/\/doi.org\/10.3390\/BIOS14080392\/S1"},{"key":"12905_CR117","doi-asserted-by":"publisher","unstructured":"Spir\u00f3 Z, El-Heliebi A, Mair MJ, Pieber TR, Prietl B, Spiegl-Kreinecker S et al (2026) Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges. Cancer Treat Rev [Internet]. W.B. Saunders Ltd; [cited 2026 Jun 9];143. https:\/\/doi.org\/10.1016\/j.ctrv.2025.103072","DOI":"10.1016\/j.ctrv.2025.103072"},{"key":"12905_CR118","doi-asserted-by":"publisher","unstructured":"Kundu S, Ray MD, Sharma A (2021) Interplay between genome organization and epigenomic alterations of pericentromeric DNA in cancer. 48:184\u2013197 [cited 2026 Mar 23];. https:\/\/doi.org\/10.1016\/j.jgg.2021.02.004. Journal of Genetics and Genomics [Internet]","DOI":"10.1016\/j.jgg.2021.02.004"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12905-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12905-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:55:44Z","timestamp":1792173344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12905-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12905"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12905-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1754"}}